176 related articles for article (PubMed ID: 22287720)
1. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages.
Tai SK; Chang HC; Lan KL; Lee CT; Yang CY; Chen NJ; Chou TY; Tarng DC; Hsieh SL
J Immunol; 2012 Mar; 188(5):2464-71. PubMed ID: 22287720
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3.
Chang YC; Chen TC; Lee CT; Yang CY; Wang HW; Wang CC; Hsieh SL
Blood; 2008 May; 111(10):5054-63. PubMed ID: 18349319
[TBL] [Abstract][Full Text] [Related]
3. Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function.
Wang YL; Chou FC; Sung HH; Fan PL; Hsueh CW; Lin WC; Chen SJ; Lin WW; Sytwu HK
Mol Immunol; 2010 Oct; 47(16):2552-62. PubMed ID: 20801512
[TBL] [Abstract][Full Text] [Related]
4. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
Lin WW; Hsieh SL
Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
[TBL] [Abstract][Full Text] [Related]
6. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
Han B; Wu J
J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
Han B; Moore PA; Wu J; Luo H
Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
[TBL] [Abstract][Full Text] [Related]
8. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
[TBL] [Abstract][Full Text] [Related]
9. CMRF-35-like molecule 3 preferentially promotes TLR9-triggered proinflammatory cytokine production in macrophages by enhancing TNF receptor-associated factor 6 ubiquitination.
Wu Y; Zhu X; Li N; Chen T; Yang M; Yao M; Liu X; Jin B; Wang X; Cao X
J Immunol; 2011 Nov; 187(9):4881-9. PubMed ID: 21940676
[TBL] [Abstract][Full Text] [Related]
10. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
11. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
Hsieh SL; Lin WW
J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
[TBL] [Abstract][Full Text] [Related]
12. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
[TBL] [Abstract][Full Text] [Related]
13. Decoy receptor 3 inhibits renal mononuclear leukocyte infiltration and apoptosis and prevents progression of IgA nephropathy in mice.
Ka SM; Hsieh TT; Lin SH; Yang SS; Wu CC; Sytwu HK; Chen A
Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1218-30. PubMed ID: 21900455
[TBL] [Abstract][Full Text] [Related]
14. γ-Irradiated cancer cells promote tumor growth by activation of Toll-like receptor 1-mediated inducible nitric oxide synthase in macrophages.
Ryu YK; Lee MH; Lee J; Lee JW; Jang SJ; Kang JH; Moon EY
J Leukoc Biol; 2015 Apr; 97(4):711-21. PubMed ID: 25632046
[TBL] [Abstract][Full Text] [Related]
15. DcR3 suppresses influenza virus-induced macrophage activation and attenuates pulmonary inflammation and lethality.
Huang MT; Chen ST; Wu HY; Chen YJ; Chou TY; Hsieh SL
J Mol Med (Berl); 2015 Oct; 93(10):1131-43. PubMed ID: 25940317
[TBL] [Abstract][Full Text] [Related]
16. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
[TBL] [Abstract][Full Text] [Related]
18. Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion.
Cheng CP; Sytwu HK; Chang DM
J Rheumatol; 2011 Dec; 38(12):2522-35. PubMed ID: 21885501
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of Th1 response in decoy receptor 3 transgenic mice.
Hsu TL; Wu YY; Chang YC; Yang CY; Lai MZ; Su WB; Hsieh SL
J Immunol; 2005 Oct; 175(8):5135-45. PubMed ID: 16210617
[TBL] [Abstract][Full Text] [Related]
20. Expression of decoy receptor 3 in liver tissue microarrays.
Chen G; Luo D
Natl Med J India; 2008; 21(6):275-8. PubMed ID: 19691215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
